EOElodie Olivier

Elodie Olivier

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elodie Olivier has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A dimer peptide ligand of vascular endothelial growth factor slows the progression of human gastric tumors in mouse xenografts

    by Xiaoqing Ye, Haofeng Hu, Yilei He, Fei Ye, Jia Jin, Elodie Olivier, Jean-François Gaucher, Lei Wang, Sylvain Broussy

    Gastric cancer is among the most common cancers and represents a major public health problem worldwide. New therapeutic strategies and drugs are needed. Anti-angiogenic agents targeting the Vascular Endothelial Growth Factor (VEGF) are used in combination therapy in the clinic, although their efficacy remains modest. We believe that these large anti-VEGF antibodies could be advantageously replaced by smaller peptides with better tissue penetration. In this study, we evaluate the efficacy of a previously described dimer peptide ligand of VEGF, D6 , in inhibiting the proliferation of gastric cancer cells and the growth of the corresponding murine xenograft. The activity of the D6 peptide in these assays was comparable to that of bevacizumab, the positive control antibody, although the peptide required repeated injections at higher molar concentrations. These promising results justify the continued optimization of the peptide dimer, currently under investigation in our laboratory.

  • Open Access

    Rational design and synthesis of a heterocycle scaffold for DNMT3A inhibition

    by Ting Chen, Ahmad Elbahnsi, Elodie Olivier, Syrine Mahdadi, Corinne Jallet, Guilaine Nchugoua, Paola B. Arimondo, Maria A. Miteva, Stephanie Desbène-Finck

    DNA methylation, a crucial epigenetic modification involved in human diseases, is catalyzed by DNA methyltransferases (DNMTs). This study presents a rational design strategy for developing selective DNMT3A inhibitors based on a cytosine-containing scaffold. Building on the most potent compound identified from enzymatic activity screening, MOE scaffold replacement was employed to generate a focused virtual library of 5827 analogs. Subsequent drug-likeness and synthetic accessibility filtering narrowed the set to 82 candidates. Among the synthesized derivatives, two lead compounds (6a and 8b) exhibited some selective inhibition of DNMT3A over DNMT1 in enzymatic assays, showing an IC50 values around 30 μM against DNMT3A, while IC50 values against DNMT1 were significantly higher (>320 μM). Molecular dynamics simulations confirmed stable binding of the compounds to DNMT3A. In addition, the two compounds demonstrated anti-proliferative effects in HCT116 colorectal cancer cells, with compound 6a showing greater potency. These findings highlight 6a and 8b as promising starting point for further development of DNMT3A-selective inhibitors.

  • Role of Oxysterols in Ocular Degeneration Mechanisms and Involvement of P2X7 Receptor

    by Elodie Olivier, Patrice Rat

    Ocular degeneration, including cataracts, glaucoma, macular degeneration, and diabetic retinopathy, is a major public health challenge, as it affects the quality of life of millions of people worldwide and, in its advanced stages, leads to blindness. Ocular degeneration, although it can affect different parts of the eye, shares common characteristics such as oxysterols and the P2X7 receptor. Indeed, oxysterols, which are cholesterol derivatives, are associated with ocular degeneration pathogenesis and trigger inflammation and cell death pathways. Activation of the P2X7 receptor is also linked to ocular degeneration and triggers the same pathways. In age-related macular degeneration, these two key players have been associated, but further studies are needed to extrapolate this interrelationship to other ocular degenerations. Keywords P2X7 Oxysterol Ocular degeneration


  • Open Access

    Cocktail Effect of Endocrine Disrupting Chemicals: Application to Chlorpyrifos in Lavender Essential Oils

    by Sophie Fouyet, Elodie Olivier, Pascale Leproux, Sabrina Boutefnouchet, Mélody Dutot, Patrice Rat

    Chlorpyrifos is a pesticide that is toxic to human health and has been banned for the past decade. Due to its persistent and bioaccumulative properties, chlorpyrifos is still present in soil. Pregnant women can be exposed to chlorpyrifos through drinking water and herbal products, such as essential oils (EOs), resulting in adverse effects to the mother and fetus. Our objective was to evaluate and compare the potential endocrine disrupting effects of chlorpyrifos “free” or in contaminated lavender EO. We studied the release of four hormones and the activation of the P2X7 cell death receptor in human placental JEG-Tox cells as key biomarkers of endocrine toxicity for pregnant women (hPlacentox assay). We observed that “free” chlorpyrifos disrupted placental hormones and activated the P2X7 receptor, whereas chlorpyrifos in lavender EO disrupted only the placental hormones. We confirm that chlorpyrifos can be classified as an endocrine disrupting chemical (EDC) for pregnant women and point out that its endocrine disrupting effect may not be apparent when present in lavender EOs. Our results reveal the existence of specific reverse cocktail effects that may have protective properties against EDCs.


  • Open Access

    Forskolin Induces Endocrine Disturbance in Human JEG-3 Placental Cells

    by Patrice Rat, Pascale Leproux, Sophie Fouyet, Elodie Olivier

    Forskolin, used in folk medicine since ancient times, is now available as a dietary supplement, with an indication as a fat burner and appetite suppressant. However, the safety of forskolin is poorly documented especially for pregnant women. The question that we raised is what about the safety of forskolin in pregnant women? As the placenta, an endocrine organ, is the key organ of pregnancy, we evaluated the in vitro placental toxicity of forskolin. We focused first on the activation of a P2X7 degenerative receptor as a key biomarker for placental toxicity, and second on steroid and peptide hormonal secretion. We observed that forskolin activated P2X7 receptors and disturbed estradiol, progesterone, hPL and hyperglycosylated hCG secretion in human placental JEG-Tox cells. To the best of our knowledge, we highlighted, for the first time, that forskolin induced endocrine disturbance in placental cells. Forskolin does not appear to be a safe product for pregnant women and restrictions should be taken.


  • Open Access

    Evaluation of Placental Toxicity of Five Essential Oils and Their Potential Endocrine-Disrupting Effects

    by Sophie Fouyet, Elodie Olivier, Pascale Leproux, Mélody Dutot, Patrice Rat

    Pregnant women may use EOs in case of morning sickness, nausea, stress management, etc. Little is known about the potential danger that EOs represent for the placenta and therefore for the pregnancy. Our aim was to explore and compare the placental toxicity and potential endocrine disrupting effects of niaouli, orange, tea tree, wintergreen and ylang-ylang EOs, and their key compounds: 4-terpineol, 1,8-cineol, limonene, methyl salicylate and benzyl salicylate. We studied the release of four hormones and the activation of P2X7 receptor in JEG-Tox human placental cells as key biomarkers for endocrine toxicity. We observed that niaouli, orange, tea tree, wintergreen and ylang-ylang EOs and their key components disrupted at least one of the studied hormones but none of them activated the P2X7 cell death receptor. The tested EOs appear then to be more hormonal modulators rather than EDCs in human placental cells. The hormonal effects observed with the key components were very different from those observed with the EOs. EOs are very complex mixtures, and it is essential to study whole EOs rather than their components individually in safety assessment.


  • Open Access

    Pregnant Women and Endocrine Disruptors: Role of P2X7 Receptor and Mitochondrial Alterations in Placental Cell Disorders

    by Sophie Fouyet, Elodie Olivier, Pascale Leproux, Mélody Dutot, Patrice Rat

    In pregnant women, the lungs, skin and placenta are exposed daily to endocrine-disrupting chemicals (EDCs). EDCs induce multiple adverse effects, not only on endocrine organs, but also on non-endocrine organs, with the P2X7 cell death receptor being potentially the common key element. Our objective was first to investigate mechanisms of EDCs toxicity in both endocrine and non-endocrine cells through P2X7 receptor activation, and second, to compare the level of activation in lung, skin and placental cells. In addition, apoptosis in placental cells was studied because the placenta is the most exposed organ to EDCs and has essential endocrine functions. A total of nine EDCs were evaluated on three human cell models. We observed that the P2X7 receptor was not activated by EDCs in lung non-endocrine cells but was activated in skin and placenta cells, with the highest activation in placenta cells. P2X7 receptor activation and apoptosis are pathways shared by all tested EDCs in endocrine placental cells. P2X7 receptor activation along with apoptosis induction could be key elements in understanding endocrine placental and skin disorders induced by EDCs.


  • Open Access

    Bisphenol A, Bisphenol F, and Bisphenol S: The Bad and the Ugly. Where Is the Good?

    by Sophie Fouyet, Elodie Olivier, Pascale Leproux, Mélody Dutot, Patrice Rat

    Background: Bisphenol A (BPA), a reprotoxic and endocrine-disrupting chemical, has been substituted by alternative bisphenols such as bisphenol F (BPF) and bisphenol S (BPS) in the plastic industry. Despite their detection in placenta and amniotic fluids, the effects of bisphenols on human placental cells have not been characterized. Our objective was to explore in vitro and to compare the toxicity of BPA to its substitutes BPF and BPS to highlight their potential risks for placenta and then pregnancy. Methods: Human placenta cells (JEG-Tox cells) were incubated with BPA, BPF, and BPS for 72 h. Cell viability, cell death, and degenerative P2X7 receptor and caspases activation, and chromatin condensation were assessed using microplate cytometry and fluorescence microscopy. Results: Incubation with BPA, BPF, or BPS was associated with P2X7 receptor activation and chromatin condensation. BPA and BPF induced more caspase-1, caspase-9, and caspase-3 activation than BPS. Only BPF enhanced caspase-8 activity. Conclusions: BPA, BPF, and BPS are all toxic to human placental cells, with the P2X7 receptor being a common key element. BPA substitution by BPF and BPS does not appear to be a safe alternative for human health, particularly for pregnant women and their fetuses.


  • Open Access

    JEG-3 placental cells in toxicology studies: a promising tool to reveal pregnancy disorders

    by Elodie Olivier, Anaïs Wakx, Sophie Fouyet, Mélody Dutot, Patrice Rat

    Elodie Olivier, Anaïs Wakx, Sophie Fouyet, Mélody Dutot, Patrice Rat. Anat Cell Biol -0001;0:. https://doi.org/10.5115/acb.20.234